Ameritas Investment Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.61M | Sell |
|
|||||
|
2025
Q2 | $2.42M | Sell |
|
|||||
|
2025
Q1 | $2.17M | Sell |
|
|||||
|
2024
Q4 | $2.77M | Sell |
|
|||||
|
2024
Q3 | $2.39M | Sell |
|
|||||
|
2024
Q2 | $2.95M | Sell |
|
|||||
|
2024
Q1 | $3.03M | Buy |
|
|||||
|
2023
Q4 | $2.86M | Sell |
|
|||||
|
2023
Q3 | $2.46M | Sell |
|
|||||
|
2023
Q2 | $2.3M | Sell |
|
|||||
|
2023
Q1 | $2.49M | Sell |
|
|||||
|
2022
Q4 | $2.71M | Buy |
|
|||||
|
2022
Q3 | $2.61M | Sell |
|
|||||
|
2022
Q2 | $2.47M | Hold |
|
|||||
|
2022
Q1 | $2.38M | Hold |
|
|||||
|
2021
Q4 | $2.16M | Buy |
|
|||||
|
2021
Q3 | $2.4M | Sell |
|
|||||
|
2021
Q2 | $2.49M | Sell |
|
|||||
|
2021
Q1 | $2.51M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $263K | Hold |
|
|||||
|
2015
Q4 | $377K | Buy |
|
|||||
|
2015
Q3 | $262K | Hold |
|
|||||
|
2015
Q2 | $315K | Sell |
|
|||||
|
2015
Q1 | $296K | Buy |
|